|
Mr. Palekar joined Medivation as chief commercial officer in January 2008, following a 16-year commercial career at the Johnson & Johnson family of companies in positions of increasing seniority. From 2005 to 2008, Mr. Palekar served as vice president, sales and marketing dermatology for Centocor, Inc., where he led the sales and marketing group for Remicade�, a multi-billion dollar anti-TNF antibody. From 2003 to 2005, Mr. Palekar was worldwide vice president, global biologics strategic marketing for Centocor, where he managed a portfolio of more than ten molecules targeting a broad range of indications. Mr. Palekar also served as a member of the Johnson & Johnson Pharmaceuticals Group Marketing Excellence Steering Committee. Mr. Palekar earned a Bachelor of Commerce and a Bachelor of General Laws from the University of Bombay and a Master of Business Administration from the Amos Tuck School of Business Administration at Dartmouth College. | 